US 11497734
Dual inhibitors of TIM-3 and PD-1 pathways
granted A61KA61K31/4245A61K31/454
Quick answer
US patent 11497734 (Dual inhibitors of TIM-3 and PD-1 pathways) held by Aurigene Discovery Technologies Limited expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/4245, A61K31/454, A61K31/5377, A61K45/06